Actively Recruiting
Study to Understand Genetic and Developmental Causes of Biliary Atresia and Its Effects on Liver Health in Children Undergoing or Awaiting Liver Transplant
Led by University of Pittsburgh · Updated on 2026-08-10
1100
Participants Needed
1
Research Sites
239 weeks
Total Duration
AI-Summary
What this Trial Is About
Researchers are studying biliary atresia BA, a rare childhood liver disease that causes bile drainage failure and often leads to liver failure requiring transplantation. This research aims to understand the genetic and developmental causes of BA, which includes both isolated cases possibly due to viral infection and syndromic cases linked to genetic factors. The study combines genetic analysis with human tissue and animal models to uncover the pathways involved in this complex disease. The study collects human DNA samples from 1100 individuals with BA and their family members, using these to identify susceptibility genes. Samples and data from major pediatric liver transplant centers worldwide are analyzed with advanced bioinformatics and experimental models like zebrafish. The goal is to map genetic pathways that explain the diseases effects on the liver and other organs. Participants provide DNA samples and clinical information. Researchers study these samples alongside liver tissue and animal models to measure genomic pathways related to BA over two years, with extended observation for genetic predisposition outcomes over four years. This study involves no interventions but focuses on detailed genetic and developmental assessments to inform future management of BA.
CONDITIONS
Brief Title
Mapping Disease Pathways for Biliary Atresia
Research Team
M
Morgan L Paul, BSN
D
Daniel Pieratt, MPA
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here